Skip to content

comparision of postoperative pain relief with transdermal buprenorphine patch vs intravenous tramadol in head and neck carcinoma patients

Randomized controlled trial comparing postoperative pain relief with transdermal buprenorphine patch and intravenous tramadol in opioid naïve head and neck carcinoma patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036336
Enrollment
42
Registered
2021-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Tramadol injections vs buperonorphine patch: In head neck cancer patients tramadol injections 0.1mg/kg I/V will be compared to buperonorphine transdermal patch 10mcg/hr that which is su

Sponsors

Institute of medical sciencesBHU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients undergoing surgery for Head and Neck Carcinoma requiring reconstruction and prolonged Intubation 2)ASA physical status 1&2 3)Opioid naïve patients

Exclusion criteria

Exclusion criteria: 1)Minor head and neck superficial surgeries and in which patient is not intubated for a long time. 2)ASA physical status 3&4 3)Previous history of opioid intake for a prolonged period

Design outcomes

Primary

MeasureTime frame
To evaluate the postoperative Pain relief with transdermal buperonorphine patch applied preoperatively in patients of head and neck carcinomaTimepoint: 1hr,3hr,6hr,12hr,24hr

Secondary

MeasureTime frame
To compare the postoperative endotracheal tube tolerance with transdermal buperonorphine patch applied postoperativelyTimepoint: 1hr,3hr,6hr

Countries

India

Contacts

Public ContactDr Nimisha Verma

Institute of Medical Sciences, BHU, Varanasi

verma.nimisha5@gmail.com9559955988

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026